08.01.26 -- Drug Delivery Leader Best Of July

In this segment of the Drug Delivery Leader Live online event, Advanced Oral Delivery: Maximizing Molecules, Targets, And Adherence, Chief Editor Tom von Gunden asks panelist Firouz Asgarzadeh to highlight key breakthroughs in oral drug delivery effectiveness. Asgarzadeh underscores advances in bioavailability. Panelists Jing Ling and Eduardo Jule weigh in on solubility and the foundational function of the Target Product Profile (TPP). 

In this article, Fran DeGrazio identifies six aspects of biologics-based therapy packaging and delivery that, if addressed, may help to ensure successful product development and lifecycle management. They include 1) chemical compatibility with device functionality, 2) long-acting formulations, 3) product stability, 4) primary packaging and device integration, 5) cold storage, and 6) higher concentrations and viscosities. 

In this segment of the Drug Delivery Leader Live online event, Just Breathe: Increasing Efficacy And Expanding Targets With Inhalation Delivery, Chief Editor Tom von Gunden asks panelist Nani Kadrichu to trace the evolution of inhalation drug delivery. In an introductory overview of the science and technology, Kadrichu describes the development and current state of oral and nasal approaches to targeting respiratory and systemic conditions. 

Fill‑finish is evolving as biologics and advanced therapies shift capacity and sterility needs. Automation, emerging tech, and data‑driven methods are boosting efficiency in aseptic production.

The ability to administer high doses of biologics offers numerous benefits, including reduced treatment burden, improved patient convenience, and increased adherence to treatment regimens.

Learn about the importance of selecting the right container for sensitive drug products and how close collaboration is crucial for avoiding commercialization delays and safety risks to patients.